First Light Asset Management’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

First Light Asset Management’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-204,600	Closed	-$25.7M	–	85
2021 Q3	$25.7M	Buy	204,600 +121,931	+147%	+$15.7M	1.69%	24
2021 Q2	$11.2M	Buy	+82,669	New	+$10.9M	0.67%	40
2018 Q1	–	Sell	-9,499	Closed	-$806K	–	54
2017 Q4	$806K	Hold	9,499	–	–	0.22%	45
2017 Q3	$822K	Hold	9,499	–	–	0.26%	44
2017 Q2	$733K	Hold	9,499	–	–	0.25%	47
2017 Q1	$659K	Sell	9,499 -2,537	-21%	-$170K	0.25%	45
2016 Q4	$712K	Buy	12,036 +4,446	+59%	+$274K	0.31%	43
2016 Q3	$503K	Buy	+7,590	New	+$470K	0.22%	45

Other funds holding XBI

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

First Light Asset Management's XBI Position: Q4 2021 in Review

First Light Asset Management sold out of State Street SPDR S&P Biotech ETF (XBI) in Q4 2021, closing a stake of 204,600 shares — an estimated $25.7M sold.

First Light Asset Management first reported a position in XBI in Q3 2016 and held it in 8 quarters. The position peaked at $25.7M in Q3 2021. 702 funds tracked by Wall St. Rank hold XBI as of Q4 2021.

First Light Asset Management reported no remaining State Street SPDR S&P Biotech ETF position as of Q4 2021 after selling out during the quarter.
First Light Asset Management sold 204,600 State Street SPDR S&P Biotech ETF shares in Q4 2021, an estimated $25.7M.
First Light Asset Management first reported a position in State Street SPDR S&P Biotech ETF in Q3 2016 and held it in 8 quarters.
First Light Asset Management's State Street SPDR S&P Biotech ETF position peaked at $25.7M in Q3 2021.
702 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q4 2021.

Based on First Light Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.